Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward

Abstract

The prevalence of both organic valvular heart disease (VHD) and cardiac arrhythmias is high in the general population, and their coexistence is common. Both VHD and arrhythmias in the elderly lead to an elevated risk of hospitalization and use of health services. However, the relationships of the two conditions is not fully understood and our understanding of their coexistence in terms of contemporary management and prognosis is still limited. VHD-induced left ventricular dysfunction/hypertrophy and left atrial dilation lead to both atrial and ventricular arrhythmias. On the other hand, arrhythmias can be considered as an independent condition resulting from a coexisting ischemic or non-ischemic substrate or idiopathic ectopy. Both atrial and ventricular VHD-induced arrhythmias may contribute to clinical worsening and be a turning point in the natural history of VHD. Symptoms developed in patients with VHD are not specific and may be attributable to hemodynamical consequences of valve disease but also to other cardiac conditions including arrhythmias which are notably prevalent in this population. The issue how to distinguish symptoms related to VHD from those related to atrial fibrillation (AF) during decision making process remains challenging. Moreover, AF is a traditional limit of echocardiography and an important source of errors in assessment of the severity of VHD. Despite recent progress in understanding the pathophysiology and prognosis of postoperative AF, many questions remain regarding its prevention and management. Furthermore, life-threatening ventricular arrhythmias can predispose patients with VHD to sudden cardiac death. Evidence for a putative link between arrhythmias and outcome in VHD is growing but available data on targeted therapies for VHD-related arrhythmias, including monitoring and catheter ablation, is scarce. Despite growing evidences, more research focused on the prognosis and optimal management of VHD-related arrhythmias is still required. We aimed to review the current evidence and identify gaps in knowledge about the prevalence, prognostic considerations, and treatment of atrial and ventricular arrhythmias in common subtypes of organic VHD.

Arrhythmic mitral valve prolapse in 2023: Evidence-based update

“…The most common PVC and non-sustained VT morphology was associated with the PPM. Other PVC morphologies suggestive of the mitral valve apparatus as the origin have been described in the setting of patients with arrhythmic MVP, including the antero-lateral papillary muscle, aorto-mitral continuity, or peri-mitral valve area, as well as more distant sites, such as the outflow tract, moderator band, or fascicular sites (Figure 2) (2,15,16).…”

Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways

“…222,223 Moreover, valvular calcification results in valvular stenosis, causing decreased blood flow through the valve, which results in organ hypoperfusion, heart failure, and arrhythmia due to electrical disturbances in the heart. 224,225 Blood Pressure Regulation…”

New Kid on the Block: Double-Peak Strain Pattern in Arrhythmic Mitral Valve Prolapse

“…7 VAs in the absence of LGE might be attributed to interstitial fibrosis or other disease processes, for example, inflammation or ischemia. [8][9][10] Late gadolinium sequence strength lies in its ability to detect replacement fibrosis. However, it lacks sensitivity at detecting interstitial fibrosis compared with parametric mapping techniques, for example, T1 and extracellular volume.…”